politics · Monday, May 18, 2026 · 3 min
CFTC is winning the prediction-market state-by-state lawsuit war and CME just popped 8% to $305.12: wait on CME
The federal commodity regulator filed a fifth lawsuit this month telling states they cannot ban prediction markets. CME, the federally-regulated exchange that benefits most, gapped up 8% to $305.12. Do not chase it here. Wait for a pullback near $297.
Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.
Watch $297.00: 50-day moving average and the prior breakout shelf from early May. If price retraces here and holds, the gap fill becomes a buy.
Watch $282.50: 200-day moving average and the deeper accumulation zone from late April. A flush to this level on a state-court setback would be the high-conviction add.
Why this size: Zero. The thesis is right but the entry is wrong. After an 8% single-day gap with the momentum gauge at 74.68 (overbought, approaching extreme), the math on a stop-loss is unworkable: either you place the stop tight under today's low at $297.87 and risk 2.4%, which means a single intraday flush takes you out, or you place a wider stop and your risk/reward collapses. Better to wait for the gap to fill or for the next prediction-market headline to fade and buy weakness.
When you'd hold this: 2 to 6 weeks, around Sixth Circuit ruling on CFTC amicus brief, no fixed date; next CME earnings late July 2026
The federal regulator that polices commodity futures (the CFTC) just filed its fifth lawsuit or court brief this month telling state governments they are not allowed to ban prediction markets1. The big federally-regulated exchange that benefits most from this fight, CME Group, gapped up 8% today to $305.12. Do not buy it here. Wait.
What just happened
Prediction markets are websites where you can bet real money on whether something will happen: who wins an election, whether the Fed cuts rates, whether a hurricane makes landfall. Two big platforms (Kalshi and Polymarket) operate nationally under federal rules. A handful of state attorneys general have tried to ban or restrict them, arguing the bets look like gambling under state law.
On May 12 the CFTC filed an amicus brief in the Sixth Circuit (the federal appeals court that covers Ohio, Michigan, Kentucky, and Tennessee) arguing that a lower court in Ohio took an "improperly narrow view" of the agency's authority1. The chairman, Michael Selig, said the agency "will not allow overzealous state governments to undermine" federal jurisdiction. That brief is the latest in a streak: in the past six weeks the CFTC has sued Wisconsin, sued New York, sued Arizona (and got a temporary restraining order blocking enforcement there), filed in Massachusetts, and sued a "trio of states" in early April1.
Meanwhile CME Group, the Chicago exchange that runs federally-regulated event contracts on Fed rate decisions and other macro outcomes, gapped up almost 8% today on heavy volume.
So what
Here is the chain. The CFTC keeps suing states and keeps winning the early rounds. Which means federal rules, not state rules, govern who can run a prediction market in the United States. Which means CME, which is already a federally-regulated exchange with decades of compliance infrastructure, becomes the natural home for the wholesale plumbing as the event-contract market grows. Which means CME collects clearing fees on a category that was a rounding error two years ago and is on track to be a meaningful new revenue line.
The market figured this out today and bid the stock 8% higher in a single session. That is the problem. The thesis is correct but the easy money on this specific news has already been taken by traders who reacted in the first hour.
What to do about it
Do not buy CME today at $305.12. The momentum gauge is at 74.68, which means the price has run up so far so fast that pullbacks of 4% to 7% from here are normal. If you want exposure, set an alert at $297 (where the 50-day average and the prior breakout level sit) and another at $282.50 (where the 200-day average sits). If the stock pulls back to the first level on no bad news, that is your spot. If a state court hands the CFTC a real loss in the next few weeks and CME flushes to $282.50, that is the high-conviction add.
If you already own CME, do not chase the rip by adding here. Let it cool.
What we got right (and wrong) before
We wrote about prediction markets a week ago from a totally different angle: a Nevada Democrat introduced a bill to ban members of Congress from trading on prediction markets, and we said buy DKNG at $25.15 with a stop at $22.50. That trade is still open. Today's signal is cleaner (federal preemption is a tailwind for incumbents) but the entry is worse (CME just gapped). Two posts on the same theme is a sign the regulatory story has legs; one buy and one stand-aside on different names is the honest read.
For the nerds
CME quote 2026-05-18: $305.12, +7.98% on the day, volume 1.84M2. RSI(14) at 74.68 (overbought, approaching extreme). MACD histogram +2.55, bullish crossover above signal. Price above SMA50 ($296.99) and SMA200 ($282.49), trend intact. 52-week high $329.16. Gap from prior close $282.58 to today's open $297.87 is unfilled.
CFTC press release stream relevant to thesis: 9230-26 (5/12 Sixth Circuit amicus), 9220-26 (4/24 Wisconsin suit), 9219-26 (4/24 Massachusetts SJC filing), 9218-26 (4/23 New York suit), 9211-26 (4/10 Arizona TRO won), 9208-26 (4/3 Arizona civil/criminal injunction sought), 9206-26 (4/2 trio-of-states suit), 9131-26 (5/12 no-action letter on event contract data reporting)1. Eight CFTC actions in 41 days, all directionally pro-federal-preemption.
Not financial advice. Do your own research.
What we passed on
- $NDAQPENDING-0.1% since pass
Up 4.66% today on the same news but no direct prediction-market product line. The story does not really fit.
- $ICEPENDING-5.2% since pass
Down 1.16% on the day. It owns the New York Stock Exchange and has no event-contract franchise to benefit from federal preemption.